Literature DB >> 17438045

Statistical methods for establishing quality control ranges for antibacterial agents in Clinical and Laboratory Standards Institute susceptibility testing.

John Turnidge1, Gerry Bordash.   

Abstract

Quality control (QC) ranges for antimicrobial agents against QC strains for both dilution and disk diffusion testing are currently set by the Clinical and Laboratory Standards Institute (CLSI), using data gathered in predefined structured multilaboratory studies, so-called tier 2 studies. The ranges are finally selected by the relevant CLSI subcommittee, based largely on visual inspection and a few simple rules. We have developed statistical methods for analyzing the data from tier 2 studies and applied them to QC strain-antimicrobial agent combinations from 178 dilution testing data sets and 48 disk diffusion data sets, including a method for identifying possible outlier data from individual laboratories. The methods are based on the fact that dilution testing MIC data were log normally distributed and disk diffusion zone diameter data were normally distributed. For dilution testing, compared to QC ranges actually set by CLSI, calculated ranges were identical in 68% of cases, narrower in 7% of cases, and wider in 14% of cases. For disk diffusion testing, calculated ranges were identical to CLSI ranges in 33% of cases, narrower in 8% of cases, and 1 to 2 mm wider in 58% of cases. Possible outliers were detected in 8% of diffusion test data but none of the disk diffusion data. Application of statistical techniques to the analysis of QC tier 2 data and the setting of QC ranges is relatively simple to perform on spreadsheets, and the output enhances the current CLSI methods for setting of QC ranges.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17438045      PMCID: PMC1913260          DOI: 10.1128/AAC.01457-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Quality control guidelines for testing gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods.

Authors:  Ronald N Jones; Tamara R Anderegg; Jana M Swenson
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

2.  Epidemiological MIC cut-off values for tigecycline calculated from Etest MIC values using normalized resistance interpretation.

Authors:  Göran Kronvall; Inga Karlsson; Mats Walder; Mikael Sörberg; Lennart E Nilsson
Journal:  J Antimicrob Chemother       Date:  2006-01-12       Impact factor: 5.790

3.  Broth microdilution susceptibility testing of Brucella species: quality control limits for ten antimicrobial agents against three standard quality control strains.

Authors:  Steven D Brown; Maria M Traczewski
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

4.  Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study.

Authors:  T L Gavan; R N Jones; A L Barry; P C Fuchs; E H Gerlach; J M Matsen; L B Reller; C Thornsberry; L D Thrupp
Journal:  J Clin Microbiol       Date:  1981-07       Impact factor: 5.948

5.  Broth microdilution susceptibility testing of Campylobacter jejuni and the determination of quality control ranges for fourteen antimicrobial agents.

Authors:  Patrick F McDermott; Sonya M Bodeis-Jones; Thomas R Fritsche; Ronald N Jones; Robert D Walker
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

6.  Comparative in vitro antimicrobial activity of a new carbapenem, doripenem: tentative disc diffusion criteria and quality control.

Authors:  Steven D Brown; Maria M Traczewski
Journal:  J Antimicrob Chemother       Date:  2005-05-04       Impact factor: 5.790

  6 in total
  25 in total

1.  Initial broth microdilution quality control guidelines for Debio 1452, a FabI inhibitor antimicrobial agent.

Authors:  James E Ross; Robert K Flamm; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2015-08-31       Impact factor: 5.191

Review 2.  Setting and revising antibacterial susceptibility breakpoints.

Authors:  John Turnidge; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

3.  Multicenter Investigation of Gepotidacin (GSK2140944) Agar Dilution Quality Control Determinations for Neisseria gonorrhoeae ATCC 49226.

Authors:  Ronald N Jones; Kelley A Fedler; Nicole E Scangarella-Oman; James E Ross; Robert K Flamm
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

4.  Determination of disk diffusion and MIC quality control guidelines for GSK2140944, a novel bacterial type II topoisomerase inhibitor antimicrobial agent.

Authors:  James E Ross; Nicole E Scangarella-Oman; Robert K Flamm; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2014-04-23       Impact factor: 5.948

5.  Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum.

Authors:  Ken B Waites; Lynn B Duffy; Cécile M Bébéar; Anne Matlow; Deborah F Talkington; George E Kenny; Patricia A Totten; Donald J Bade; Xiaotian Zheng; Maureen K Davidson; Virginia D Shortridge; Jeffrey L Watts; Steven D Brown
Journal:  J Clin Microbiol       Date:  2012-08-22       Impact factor: 5.948

6.  Disk diffusion and MIC quality control ranges for BC-3205 and BC-3781, two novel pleuromutilin antibiotics.

Authors:  James E Ross; Helio S Sader; Zrinka Ivezic-Schoenfeld; Susanne Paukner; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2012-07-18       Impact factor: 5.948

7.  Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales.

Authors:  A Espinel-Ingroff; A Chakrabarti; A Chowdhary; S Cordoba; E Dannaoui; P Dufresne; A Fothergill; M Ghannoum; G M Gonzalez; J Guarro; S Kidd; C Lass-Flörl; J F Meis; T Pelaez; A M Tortorano; J Turnidge
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

8.  Determination of disk diffusion and MIC quality control ranges for GSK1322322, a novel peptide deformylase inhibitor.

Authors:  James E Ross; Nicole E Scangarella-Oman; Linda A Miller; Helio S Sader; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2011-09-14       Impact factor: 5.948

9.  Determination of disk diffusion and MIC quality control guidelines for JNJ-Q2, a novel quinolone.

Authors:  James E Ross; Lisa C Liverman; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2011-06-08       Impact factor: 5.948

10.  Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for Aspergillus spp. for the CLSI M38-A2 broth microdilution method.

Authors:  A Espinel-Ingroff; A Chowdhary; G M Gonzalez; C Lass-Flörl; E Martin-Mazuelos; J Meis; T Peláez; M A Pfaller; J Turnidge
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.